Tuesday, October 14, 2014 11:40:09 AM
I know this is of little consolation to those that bought at much higher levels. But when viewed objectively, it is more supportive of a narrative that Robert Calkin has accomplished a great deal as the CEO of Green Cures (GRCU). And that many shareholders believe that he will continue on that path. I believe that the drifting downward of the share price, since the multi-penny peak, is more a reflection of what typically happens in the OTC market after nearly every since run.
I am one of those shareholders that believes in Robert's ability and commitment to accomplish a great deal with respect to Green Cures, and that is why I remain a long term holder of GRCU shares.
As always, simply my opinion.
GRCU
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM